Adeno-Associated Virus Monoinfection Induces a DNA Damage Response and DNA Repair That Contributes to Viral DNA Replication
Open accessThe DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
Recombinant AAV (rAAV) has emerged as one of the preferred delivery vectors for clinical gene therapy. rAAV production in HEK293 cells by transfection of a rAAV transgene plasmid, an AAV Rep and Cap expression packaging plasmid, and an Ad helper plasmid remains the popular method. Here, we demonstrated that the high fidelity Y family DNA repair DNA polymerase, Pol η, and Pol κ, plays a significant role in AAV DNA replication and rAAV production in HEK293T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![FIG 4 Treatment of pharmacological inhibitors that specifically target ATM, ATR, or DNA-PKcs impairs AAV2 replication in HEK293T cells. HEK293T cells were treated with vehicle control DMSO or pharmacological inhibitors targeting ATM (KU60019), ATR (AZ20), and DNA-PKcs (NU7441), respectively, at 2 days prior to pHelper transfection and AAV2 infection. (A and B) Western blotting. At 2 dpi, the cells were collected for Western blotting using specific antibodies targeting p-RPA32 (A) and p-ATM, p-ATR, and p-DNA-PKcs (B), respectively. HU-treated cells served as a DDR positive control. (C and D) Southern blotting. At 2 dpi, the cells were used to extract Hirt DNA for Southern blotting. The blot was probed for AAV2 DNA and mt DNA using an AAV2 repcap probe and a mtDNA probe, respectively. dRF, double replicative form; mRF, monomer replicative form; and ssDNA, single-stranded DNA. AAV2 DNA recovered from PvuII-digested pSSV9 was used as a size maker (M) at 4.7 kb. (E) Quantification of mRF DNA. The data were normalized to the amount of mtDNA and shown relative folds to the untreated cell group with means and standard deviations obtained from three independent experiments. P values were calculated using Student's t test (**, P < 0.01; ***, P < 0.001; ****, P < 0.0001; n.s., no statistically significant difference [P > 0.1]).](https://figures.cochat.ai/paper-figures/3b0cab821b7f4823b19b754e2704cdd6/adeno-associated-virus-monoinfection-induces-a-dna-damage-response-and-dna-figure-4.jpg)




![FIG 9 Accumulation of AAV2 genome in HEK293T, Huh7, and U2-OS cells does not induce a DDR. (A and B) Detection of p-PRA32 and AAV2 capsid proteins. HEK293T (A, left), Huh7 (A, right), and U2-OS (B) cells were infected with AAV2 at MOIs of 5,000 (5K), 10K, 50K, 100K, and 1,000K, respectively (A, lanes 3 to 7 and 10 to 14, and B, lanes 3 to 7). As an AAV2 replication control, cells were infected with AAV2 at an MOI of 5,000 and transfected with pHelper (A, lanes 8 and 15, and B, lane 8). At 2 dpi, the cells were collected and lysed for Western blotting. The blots were probed for AAV2 capsid proteins (VP1, VP2, and VP3), Rep proteins (Rep78/68/52/40), phosphorylated (p)-RPA32(T21), γH2AX(S139), and β-actin serving as a loading control. HU-treated cells were used as a DDR control. (C) Southern blotting of AAV2 genome in HEK293T cells. HEK293T cells were infected with AAV2 at an MOI of 5,000 (5K), 10K, 50K, 100K, and 1,000K, respectively. As an AAV2 replication control, cells were infected with AAV2 at an MOI of 5,000 and transfected with pHelper (C, lane 6). At 2 dpi, Hirt DNA was extracted from the infected cells, resolved in 1% agarose gel, and detected with a [α-32P]-dCTP-labeled AAV2 repcap probe and a mtDNA probe. dRF, double replicative form; mRF, monomer replicative form; ssDNA, single-stranded DNA; mtDNA as a loading control. AAV2 DNA recovered from PvuII-digested pSSV9 was used as a size maker (M).](https://figures.cochat.ai/paper-figures/5fbb0dd7239c45c4b611e5195f701d78/adeno-associated-virus-monoinfection-induces-a-dna-damage-response-and-dna-figure-9.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies report the induction of DNA damage responses by wild-type AAV 57,59,60 , as well as by recombinant AAV vectors 26,61 in different cell types.”
From AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Yet, induction of DDR genes could not be observed in some cell lines such as 2-OS, Huh7 or A549 59 , highlighting the importance of using relevant models when assessing AAV-derived signalling and toxicity.”
From AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain (2025) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“Immunofluorescence assays showed that phosphorylated ATM at serine 1981 [p-ATM (S1981)] (37), ATR at threonine 1989 [pATR (S1989)] (38), and DNA-PKcs at serine 2056 [p-DNA-PKcs (S2056)] (39) in AAV2 infected cells were associated with Rep expression (Fig.”
BackgroundATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
EUKARYOTIC TRANSLESION SYNTHESIS DNA POLYMERASES: Specificity of Structure and Function
Prakash, S., Johnson, R. E., & Prakash, L. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133250 · Cited by 1,000
Samulski, R. J., Chang, L. S., & Shenk, T. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 743
Eukaryotic Translesion Polymerases and Their Roles and Regulation in DNA Damage Tolerance
Waters, L. S., Minesinger, B. K., Wiltrout, M. E., D'Souza, S., Woodruff, R. V., & Walker, G. C. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00034-08 · Cited by 591
A dynamic model for replication protein A (RPA) function in DNA processing pathways
Fanning, E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl550 · Cited by 571
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
Samulski, R. J., & Muzyczka, N. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085355 · Cited by 551
ICTV Virus Taxonomy Profile: Parvoviridae
Cotmore, S. F., Agbandje-McKenna, M., Canuti, M., Chiorini, J. A., Eis-Hubinger, A.-M., Hughes, J., Mietzsch, M., Modha, S., Ogliastro, M., Pénzes, J. J., et al. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001212 · Cited by 523
Self-citationReplication Protein A (RPA): The Eukaryotic SSB
Iftode, C., Daniely, Y., & Borowiec, J. A. (1999) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239991209255 · Cited by 472
Maréchal, A., & Zou, L. (2015) · Cell Research · doi:10.1038/cr.2014.147 · Cited by 465 · cited 1×
“repair factors into the DNA damage foci (62, 63).”
Background
Research works printed but not linked: 1
- Berns KI, Parrish CR. 2007. Parvoviridae, p 2437-2477. In Knipe DM, Howley PM (ed), Fields virology 5th ed. Lippincott Williams, New York, NY.
Cited by
Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets
Taghdiri, M., & Mussolino, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137333 · Cited by 145
Critical challenges and advances in recombinant adeno‐associated virus (rAAV) biomanufacturing
Fu, Q., Polanco, A., Lee, Y. S., & Yoon, S. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28412 · Cited by 79
Costa-Verdera, H., Meneghini, V., Fitzpatrick, Z., Abou Alezz, M., Fabyanic, E., Huang, X., Dzhashiashvili, Y., Ahiya, A., Mangiameli, E., Valeri, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58778-3 · Cited by 32
AAV vectors trigger DNA damage responses and STING-dependent inflammation in human CNS cells
Costa-Verdera, H., Meneghini, V., Fitzpatrick, Z., Alezz, M. A., Fabyanic, E., Huang, X., Dzhashiashvili, Y., Ahiya, A., Mangiameli, E., Valeri, E., et al. (2024) · doi:10.21203/rs.3.rs-4171795/v1 · Cited by 32
Role of the membrane-associated accessory protein (MAAP) in adeno-associated virus (AAV) infection
Küz, Ç. A., Ning, K., Hao, S., Cheng, F., & Qiu, J. (2024) · Journal of Virology · doi:10.1128/jvi.00633-24 · Cited by 29
Self-citationWang, Y., Fu, Q., Park, S. Y., Lee, Y. S., Park, S., Lee, D., & Yoon, S. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108322 · Cited by 21
Hao, S., Zhang, X., Ning, K., Feng, Z., Park, S. Y., Küz, Ç. A., McFarlin, S., Richart, D., Cheng, F., Zhang, E. Y., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01330-23 · Cited by 17
Self-citationFor better or worse: crosstalk of parvovirus and host DNA damage response
Chen, S., Liu, F., Yang, A., & Shang, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1324531 · Cited by 16
Pool-packaged AAV libraries exhibit extensive length-dependent and homology-dependent chimerism
Lalanne, J., Huynh, C., Mich, J. K., Hunker, A. C., McDiarmid, T. A., Kim, H., Levi, B. P., Ting, J. T., & Shendure, J. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03097-1 · Cited by 16
Seneca Valley virus infection exploits DNA damage response to facilitate viral replication
Song, J., Li, Z., Yang, J., Ma, R., Wang, D., Quan, R., Wen, X., & Liu, J. (2025) · Journal of Virology · doi:10.1128/jvi.02211-24 · Cited by 10
Maurer, A. C., Benyamini, B., Whitney, O. N., Fan, V. B., Cattoglio, C., Kissiov, D. U., Dailey, G. M., Darzacq, X., Weitzman, M. D., & Tjian, R. (2025) · Nature Communications · doi:10.1038/s41467-025-56738-5 · Cited by 10
Zhang, X., Hao, S., Feng, Z., Ning, K., Küz, Ç. A., McFarlin, S., Richart, D., Cheng, F., Zhang-Chen, A., McFarlane, R., et al. (2024) · mBio · doi:10.1128/mbio.03268-24 · Cited by 9
Self-citationZhou, M., Liu, Y., Zhang, Y., Ma, Y., Zhang, Y., Choi, S. H., Shao, S., & Wang, Q. (2024) · Communications Biology · doi:10.1038/s42003-024-05852-z · Cited by 9
Ladiwala, P., Ndahiro, N., Hauk, P., Wen, J., Sargunas, J., Chen, Y., Barton, E. S., & Betenbaugh, M. J. (2025) · Biotechnology Journal · doi:10.1002/biot.202400501 · Cited by 9
Ning, K., Zhang, X. J., Feng, Z., Hao, S., Küz, Ç. A., Cheng, F., Park, S. Y., McFarlin, S., Engelhardt, J. F., Yan, Z., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101115 · Cited by 8
Self-citationKüz, Ç. A., Ning, K., Hao, S., McFarlin, S., Zhang, X. J., Cheng, F., & Qiu, J. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101392 · Cited by 7
Self-citationSmall Genomes, Big Disruptions: Parvoviruses and the DNA Damage Response
Abrahams, R. R., & Majumder, K. (2025) · Viruses · doi:10.3390/v17040494 · Cited by 7
Li, Q., Ma, X., Shang, X., Nian, X., Mao, R., Luo, Z., Zhu, Z., Ru, Y., Fan, Y., Cao, W., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013874 · Cited by 6
Summers, M. F., Haubold, M. K., Morgenstern, M., Shepherd, P. M., Larsen, C. I. S., Bartz, A. E., Thirumoorthy, G., Kirchdoerfer, R. N., Coon, J. J., Mehta, K. P. M., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013142 · Cited by 5
Introduction of DNA Computing in Cryptography
Reddy, M. V. K., Reddy, R. R., Latha, E. P., Alamanda, S., & Srinivas, P. V. S. (2024) · Wiley eBooks · doi:10.1002/9781394287420.ch3 · Cited by 5
Lin, Y., Kuo, H., Lu, M., Rungkittikhun, C., & Hu, W. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28885 · Cited by 4
AAV Kills Dividing Cells by Depleting PARP1 and Other DNA Damage Response ProteinsPreprint
Friese, S., Zai, J., Luzbetak, G., Khanna, N., Gesperger, J., Liu, C.-H., Roos, W. P., Al‐Rahahleh, R. Q., Willardson, M., Yang, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.14.682484 · Cited by 4
AAV Assembled Capsids Are Produced in Cells Blocked From Cell Cycle Progression
Mullick, A., Morasse, A., Leclerc, M., Liu, Z., Liu, Q. Y., Leclerc, S., Momcilovic, M., Viau, A., & Kamen, A. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.70111 · Cited by 3
Park, S. Y., Feng, Z., Choi, S. H., Zhang, X., Tang, Y., Gasser, G. N., Richart, D., Yuan, F., Qiu, J., Engelhardt, J. F., et al. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.260 · Cited by 3
Self-citationNuclear Fraction Proteome Analyses During rAAV Production of AAV2-Plasmid-Transfected HEK-293 Cells
Golm, S. K., Hoffrogge, R., & Müller, K. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136315 · Cited by 2
TBC1D23–AAVR interaction drives endosome-to-TGN trafficking required for rAAV transduction
Zhang, X., Habib, A., McFarlin, S., Richart, D., Park, S. Y., Cheng, F., Wang, J., Yan, Z., & Qiu, J. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2605086123 · Cited by 2
Self-citationMcFarlin, S., Ning, K., Zhang, X., Küz, Ç. A., Zou, W., Cheng, F., Kleiboeker, S. B., Mietzsch, M., & Qiu, J. (2026) · mBio · doi:10.1128/mbio.01482-26 · Cited by 2
Self-citationPark, S. Y., Feng, Z., Zhang, X., Tang, Y., Richart, D., Vorhies, K., Qiu, J., Engelhardt, J. F., & Yan, Z. (2025) · Viruses · doi:10.3390/v17060821 · Cited by 1
Self-citationShen, W., Chen, S., Li, Z., & Yu, W. (2025) · The FASEB Journal · doi:10.1096/fj.202502611rr · Cited by 1
Song, M., Wang, S., Fei, X., & Guo, G. (2026) · Virologica Sinica · doi:10.1016/j.virs.2026.08.014 · Cited by 1
Gómez-Moreno, A., Sebastian, E. S., Moya, J., Gomollón-Zueco, P., Isola, S., Vales, Á., González‐Aseguinolaza, G., Unzu, C., & Garaigorta, U. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102459 · Cited by 1
Krämer, N., Teschner, K. E., Buve, A., Scheller, L., Brinkert, P., Ortseifen, V., & Klausing, S. (2025) · Biotechnology Progress · doi:10.1002/btpr.70030
Caffeine restricts hepatitis B virus transcription by inhibiting γ-H2AX formation
Liao, F., Wang, L., Jiang, L., Huang, W., Yang, L., Peng, L., Sun, H., Hu, Q., & Chen, W. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1706957
Patria, J. N. (2024) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/qjcy-y095
Revolutionizing Gene Therapy: An Explicative Review on Engineering Adeno-associated Virus Vectors
Nandi, S., Chandra, S., Biswas, K., Mazumder, K., Mukherjee, S., Karati, D., Bandyopadhyay, S. N., & Toro, P. D. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00561-x
Hao, S., Habib, A., Zhang, X., Ning, K., Park, S. Y., McFarlin, S., Küz, Ç. A., Richart, D., Cheng, F., Yan, Z., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.10.737643
Self-citation
Metadata
- Authors
- Ning, K., Kuz, C. A., Cheng, F., Feng, Z., Yan, Z., & Qiu, J.
- Affiliations
- University of Kansas Medical Center (US)
- Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA
- University of Iowa (US)
- Corresponding author
- Qiu, Jianming
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2023-02-28
- Volume
- 14
- Issue
- 1
- Pages
- e0352822-e0352822
- ISSN
- 2150-7511 (ISSN-L)
- PMC
- PMC9973366
- OpenAlex
- W4318620434
- Cited by
- 33
- References
- 86
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 9 · 2023: 5
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI150877, AI156448)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus, DNA damage response, DNA repair, Y-family DNA polymerases, Pol eta, ATR signaling, AAV vector production, gene therapy vectors
- MeSH terms
- Dependovirus, DNA Damage, DNA Repair, DNA Replication, DNA, Viral, Genetic Vectors, Histones, Humans, Virus Replication, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.